ProShare Advisors’s Dianthus Therapeutics DNTH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-731
| Closed | -$34K | – | 1881 |
|
|
2022
Q1 | $34K | Sell |
731
-195
| -21% | -$9.07K | ﹤0.01% | 2143 |
|
|
2021
Q4 | $67K | Sell |
926
-96
| -9% | -$6.95K | ﹤0.01% | 2248 |
|
|
2021
Q3 | $119K | Sell |
1,022
-117
| -10% | -$13.6K | ﹤0.01% | 1891 |
|
|
2021
Q2 | $178K | Buy |
1,139
+376
| +49% | +$58.8K | ﹤0.01% | 2176 |
|
|
2021
Q1 | $145K | Buy |
763
+10
| +1% | +$1.9K | ﹤0.01% | 2114 |
|
|
2020
Q4 | $94K | Buy |
753
+109
| +17% | +$13.6K | ﹤0.01% | 1997 |
|
|
2020
Q3 | $70K | Buy |
+644
| New | +$70K | ﹤0.01% | 1563 |
|
|
2020
Q1 | – | Sell |
-690
| Closed | -$167K | – | 1280 |
|
|
2019
Q4 | $167K | Sell |
690
-103
| -13% | -$24.9K | ﹤0.01% | 1630 |
|
|
2019
Q3 | $130K | Sell |
793
-5
| -0.6% | -$820 | ﹤0.01% | 1514 |
|
|
2019
Q2 | $188K | Sell |
798
-4
| -0.5% | -$942 | ﹤0.01% | 1452 |
|
|
2019
Q1 | $211K | Buy |
802
+74
| +10% | +$19.5K | ﹤0.01% | 1444 |
|
|
2018
Q4 | $66K | Buy |
+728
| New | +$66K | ﹤0.01% | 1513 |
|